Tourmaline Bio Total Revenue

Tourmaline Bio (TRML) currently reports a total revenue of $40K as of June 2025. In the prior-year period, the figure was $0. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Tourmaline Bio's total revenue history and peer comparisons.

Tourmaline Bio's total revenue changed from $0 to $40K (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tourmaline Bio's total revenue of $40K is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Tourmaline Bio reported $40K in total revenue as of June 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $40K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Tourmaline Bio, and consider following TRML for alerts when major investors trade the stock.